Skip to main content
. 2022 Apr 12;10:877759. doi: 10.3389/fped.2022.877759

Table 4.

Clinical characteristics associated with HCoV infection: comparison between single infection and viral co-infection.

Clinical feature Total HCoV infection
(N = 1,096)
Single HCoV infections
(N = 608)
HCoV Co-infections
(N = 488)
P-Value
Age (years), median (IQR) 1.0 (0.0–2.0) 1.0 (0.0–2.0) 1.0 (0.0–3.0) 0.148
Male (%) 654 (59.7%) 364 (59.9%) 290 (59.4%) 0.931
Diagnosis
Upper respiratory infection (%) 454 (41.4) 262 (43.1) 192 (39.4) 0.234
Pneumonia (%) 182 (16.6) 78 (12.8) 104 (21.3) <0.001
Acute bronchiolitis (%) 170 (15.5) 71 (11.7) 99 (20.3) <0.001
Non-specific febrile illness (%) 144 (13.1) 102 (16.8) 42 (8.6) <0.001
Croup (%) 80 (7.3) 53 (8.7) 27 (5.5) 0.058
Acute gastroenteritis (%) 56 (5.1) 38 (6.2) 18 (3.7) 0.076
Asthma attack (%) 5 (0.5) 1 (0.2) 4 (0.8) 0.178
Encephalitis (%) 5 (0.5) 3 (0.5) 2 (0.4) 1.000
History of prematurity or underlying chronic diseases (%) 270 (24.6) 163 (26.8) 107 (21.9) 0.073
Needed hospital admission (%) 832 (75.9) 450 (74.0) 382 (78.3) 0.116
Days of hospital stay, median (IQR) 4.0 (3.0–5.0) 3.0 (3.0–5.0) 4.0 (3.0–6.0) <0.001
Needed O2 supply (%) 108 (9.9) 62 (10.2) 46 (9.4) 0.746
Needed HFNC or mechanical ventilation (%) 37 (3.4) 19 (3.1) 18 (3.7) 0.730

IQR, interquartile range; HFNC, high-flow nasal cannula oxygen therapy.